Breaking News

Breast Cancer Outcomes Enhanced With Genomic Profiling

December 16, 2021 • 5:59 pm CST
(Vax Before Cancer)

Use of genomic profiling supported by validated criteria can help improve metastatic breast cancer patient outcomes, wrote Mike Bassett with MedPage Today on December 7, 2021.

Fabrice André, M.D., Ph.D., of Gustave Roussy Cancer Campus in Villejuif, France, presented significant findings during a virtual press briefing at the San Antonio Breast Cancer Symposium.

"I cannot overstate how important this clinical trial is," said discussant Virginia Kaklamani, M.D., of UT Health San Antonio in Texas.

"This is the first trial that we have where we used genomic alterations to actively change a patient's treatment plan, and we have found an improvement in the patient's outcomes," she continued.

"What we are trying to do, and which Dr. André showed so eloquently, is that by finding changes in the tumor unique to that patient, and by having targeted therapies available for that change, we're able to treat that patient with that specific targeted therapy, instead of standard of care, which would have been chemotherapy, and improve the patient's outcome."

To read the full article, please visit this webpage.